Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in COPD Patients

Chronic Obstructive Pulmonary Disease Clinical Trial

Official title:

Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in Chronic Obstructive Pulmonary Disease Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02873780
• Other study ID #: BE403201317621
• Status: Completed
• Phase: N/A
• First received: July 31, 2016
• Last updated: January 30, 2017
• Start date: July 2016
• Est. completion date: September 2016

Study information

• Verified date: January 2017
• Source: Centre Hospitalier des Pays de Morlaix
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this study is to compare oxygen desaturation during two tests: the 6 minute walk test and the 3 minute step test, for COPD patients.

Description:

The 6 minute walk test (6MWT) is the best field test to determine oxygen desaturation during effort, in COPD patients. However, the test need a 30m corridor.

The 3 minute step test (3MST) is a other field test used in COPD patients. But no study shows that 3MST can be used to determine oxygen desaturation.

The aim of this study is to compare oxygen desaturation during these to tests : the 6MWT and the 3MST.

50 patients will be included in this study.

Patients realize two 6MWT and two 3MST, with rest between each test.

Oxygen saturation, heart rate are registered during the tests, dyspnea, leg peniblility are notified before and after each test, distance or number of steps are noted.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: September 2016
• Est. primary completion date: September 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 90 Years

Eligibility

Inclusion Criteria:

• stable COPD patients hospitalized for pulmonary rehabilitation program

Exclusion Criteria:

• acute exacerbation of COPD

• incapacity to realize the tests

• absence of written informed consent

Related Conditions & MeSH terms

• Chronic Obstructive Pulmonary Disease
• COPD
• Lung Diseases
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Locations

Country	Name	City	State
France	CH Des pays de Morlaix	Morlaix

Sponsors (2)

Lead Sponsor	Collaborator
Centre Hospitalier des Pays de Morlaix	Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Country where clinical trial is conducted

France, 

References & Publications (3)

Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F, Wanger J, MacIntyre N, Kaminsky DA, Culver BH, Revill SM, Hernandes NA, Andrianopoulos V, Camillo CA, Mitchell KE, Lee AL, Hill CJ, Singh SJ. An o — View Citation

Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agustí A, Bakke PS, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Miller BE, Crim C, Yates J, Wouters EF, Celli B; Evaluation of COPD Longitudinal — View Citation

Roberts MM, Cho JG, Sandoz JS, Wheatley JR. Oxygen desaturation and adverse events during 6-min walk testing in patients with COPD. Respirology. 2015 Apr;20(3):419-25. doi: 10.1111/resp.12471. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	oxygen saturation	oxygen saturation is compared between 6MWT and 3MST at the end of the 2 tests	3 minutes
Secondary	heart rate	heart rate is compared between 6MWT and 3MST at the end of the 2 tests	3 minutes
Secondary	dyspnea (Borg Scale)	dyspnea (Borg Scale) is compared between 6MWT and 3MST at the end of the 2 tests	3 minutes
Secondary	leg penibility (Borg Scale)	leg penibility (Borg Scale) is compared between 6MWT and 3MST at the end of the 2 tests	3 minutes